These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3010852)

  • 1. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis S; Medoff G
    Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
    Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
    Polak A; Dixon DM
    Mykosen; 1987 Apr; 30(4):186-94. PubMed ID: 3035371
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.
    Kobayashi GS; Travis SJ; Medoff G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2005-6. PubMed ID: 2830843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice.
    Kobayashi GS; Travis SJ; Medoff G
    Rev Infect Dis; 1990; 12 Suppl 3():S291-3. PubMed ID: 2330487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Connolly P; Wheat LJ; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2604-8. PubMed ID: 10991831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
    Kobayashi GS; Little JR; Medoff G
    Antimicrob Agents Chemother; 1985 Mar; 27(3):302-5. PubMed ID: 3994345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
    Brilhante RS; Fechine MA; Mesquita JR; Cordeiro RA; Rocha MF; Monteiro AJ; Lima RA; Caetano ÉP; Pereira JF; Castelo-Branco DS; Camargo ZP; Sidrim JJ
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):484-8. PubMed ID: 22703696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.
    Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA
    Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
    Graybill JR; Palou E; Ahrens J
    Am Rev Respir Dis; 1986 Oct; 134(4):768-70. PubMed ID: 3021035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model.
    Kohler S; Wheat LJ; Connolly P; Schnizlein-Bick C; Durkin M; Smedema M; Goldberg J; Brizendine E
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1850-4. PubMed ID: 10858342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India.
    Kathuria S; Singh PK; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5613-6. PubMed ID: 24982084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of sordarins in murine histoplasmosis.
    Graybill JR; Najvar L; Fothergill A; Bocanegra R; de las Heras FG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1716-8. PubMed ID: 10390228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the efficacy of micafungin in the treatment of histoplasmosis using two North American strains of Histoplasma capsulatum.
    Hage CA; Connolly P; Horan D; Durkin M; Smedema M; Zarnowski R; Smith P; Wheat LJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4447-50. PubMed ID: 21670186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.